ROIVANT SCIENCES LTD
ROIV·G76279101·US·Common Stock·Healthcare - Biotechnology-13D/G
ROIV (ROIVANT SCIENCES LTD) is held by 210 institutional investors as of Q2 2026. Largest holders: FMR LLC ($2.9B), BlackRock, Inc. ($1.7B), MORGAN STANLEY ($1.5B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 128 funds bought ROIV.
210
Holders
(16 Elite)
$16.3B
Total Value
60% (214)
Consensus
128 buying - 86 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Oct 5, 2026 · Activists Aug 13, 2026 · Congress Nov 21, 2025
InsiderEBEpperly Melissa B,Exercise 18K shOct 1, 2026
InsiderEBEpperly Melissa B,Sell $608KOct 1, 2026
InsiderEBEpperly Melissa B,Sell $33KOct 1, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 219
1 / 11
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer